In a multicenter, retrospective, observational study, researchers examined real-world outcomes of patients with drug-resistant epilepsy treated with cenobamate as adjunctive treatment to other ...

Epilepsy in babies should not be underestimated. If seizures occur frequently and continuously, it can affect the growth and ...

"This technology could allow for limiting the number of procedures that are required to treat drug-resistant focal epilepsy and also provide immediate feedback as to whether or not a surgical ...

Focal epilepsy is a condition where seizures start in one part of the brain. It is the most common type of epilepsy. Antiseizure medication is usually prescribed for people with the condition ...

Rapport Therapeutics, Inc. RAP-219 Phase 2a trial in patients with refractory focal epilepsy remains on track with topline ...

Apr. 15, 2025 — Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new global ... Could an Arthritis Drug Unlock Lasting ...

Three-year data from the largest FDA-reviewed prospective neuromodulation study of safety and effectiveness in drug-resistant focal epilepsy 1 Long-term seizure reduction with a median reduction ...

Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new global study led by researchers at UCL and UTHealth Houston.

Xenon's lead asset, azetukalner, shows promise in treating focal onset seizures with positive phase IIb results and upcoming phase III data expected by end of 2025. Azetukalner's unique Kv7 ...

Get Instant Summarized Text (Gist) Common genetic variants in the genes CNIH3 and WDR26 are linked to drug resistance in focal epilepsy, affecting the efficacy of antiseizure medications. This ...